Gene Transfer-Mediated Generation of Drug-Resistant Hemopoiesis

References

• Ling V. Does P-glycoprotein predict response to chemotherapy? (Editorial). JNCI 1989; 81: 84–85
   PubMed Web of Science ®Google Scholar
• Scotto K. W., Bertino J. R. Chemotherapy susceptibility and resistance. The Molecular Basis of Cancer, J. Mendelsohn, P. M. Howley, M. A. Israel, L. A. Liotta. W. B. Saunders, Philadelphia 1994; 387–400
   Google Scholar
• Childs S., Ling V. The MDR superfamily of genes and its biological implications. Important Advances in Oncology, V. T. De Vita, jr., S. Hellman, S. R. Rosemberg. J. B. Lippincott, Philadelphia 1994; 21–36
   Google Scholar
• Weaver J. L., Szabo G., Jr., Pine P. S., Gottesmann M. M., Goldenberg S., Aszalos A. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multidrug transporter. Int. J. Cancer 1993; 54: 456–461
   PubMed Web of Science ®Google Scholar
• Raderer M., Scheithauer W. Clinical trials of agents that reverse multidrug resistance, a literature review. Cancer 1993; 72: 3553–3563
   PubMed Web of Science ®Google Scholar
• Gottesmann M. M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem 1993; 62: 385–427
   PubMed Web of Science ®Google Scholar
• Endicott J. A., Ling V. The biochemistry of P-glyco-protein-mediated multidrug resistance. Ann. Rev. Biochem 1989; 58: 131–171
   Web of Science ®Google Scholar
• Simon S. M., Schindler M. Cell biological mechanisms of multidrug resistance in tumors. Proc. Natl. Acad. Sci. USA 1994; 91: 3497–3504
   PubMed Web of Science ®Google Scholar
• Kobayashi H., Dorai T., Holland J. F., Ohnuma T. Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDRI (PGY1) ribozyme. Cancer Res 1994; 54: 1271–1275
   PubMed Web of Science ®Google Scholar
• Bone marrow transplantation, S. J. Forman, K. G. Blume, E. D. Thomas. Blackwell Scientific Publications, Boston 1994
   Google Scholar
• Ward M., Richardson C., Pioli P., Smith L., Podda S., Goff S., Hesdorffer C., Bank A. Transfer and expression of the human multiple drug resistance gene in Human CD34+ cells. Blood 1994; 84: 1408–1414
   PubMed Web of Science ®Google Scholar
• Bertolini F., De Monte L., Corsini C., Lazzari L., Lauri E., Soligo D., Ward M., Bank A., Malavasi F. Retrovirus-mediated transfer of the multidrug resistance gene into human haematopoietic progenitors. Br. J. Haematol 1994; 88: 318–324
   PubMed Web of Science ®Google Scholar
• Flasshove M., Banerjee D., Mineishi S., Li M., Bertino J. R., Moore M. A. S. Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood 1995; 85: 566–574
   PubMed Web of Science ®Google Scholar
• Magni M., Shammah S., Schirò R., Bregni M., Siena S., Di Nicola N., Dalla-Favera R., Gianni A. M. Gene therapy for drug-induced myelotoxicity: Induction of cyclophosphamide resistance by aldheyde dehydrogenase-1 gene transfer (abstract). Blood 1994; 84, (Suppl 1)
   Web of Science ®Google Scholar
• Webb M., Sorrentino B. P. Retroviral transfer of the human cytosolic aldheyde dehydrogenase gene as a means to generate cellular cyclophosphamide resistance. Blood 1994; 84, (Suppl 1)
   Web of Science ®Google Scholar
• Aran J. M., Gottesman M. M., Pastan I. Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector. Proc. Natl. Acad. Sci. USA 1994; 91: 3176–3180
   PubMed Web of Science ®Google Scholar
• Hodgson C. P. The vector void in gene therapy. Bio/Technology 1995; 13: 222–225
   PubMed Web of Science ®Google Scholar
• Sutherland H. J., Eaves C. J. Long-term culture of human myeloid cells. Culture of hematopoietic cells, R. I. Freshney, I. B. Pragnell, M. G. Freshney. Wiley-Liss, New York 1994; 139–162
   Google Scholar
• Bodine D. M., Seidel N. E., Gale M. S., Nienhius A. W., Orlic D. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 1994; 84: 1482–1491
   PubMed Web of Science ®Google Scholar
• Kruh G. D., Chan A., Myers K., Gaughan K., Miki T., Aaronson S. A. Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Res 1994; 54: 1649–1652
   PubMed Web of Science ®Google Scholar
• Galski H., Sullivan M., Willingham M. C., Chin K. W., Gottesman M. M., Pastan I. Expression of a human multidrug resistance cDNA (MDRI) in the bone marrow of transgenic mice: resistance to daunomycin-induced cytopenia. Mol. Cell. Biol 1989; 9: 4357–4363
   PubMed Web of Science ®Google Scholar
• Podda S., Ward M., Himelstein A., Richardson C., de la Flor-Weiss E., Smith L., Gottesman M., Pastan I., Bank A. Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Nat. Acad. Sci. USA 1992; 89: 9676–9680
   PubMed Web of Science ®Google Scholar
• Sorrentino B. P., Brandt S. J., Bodine D., Gottesman M., Pastan I., Cline A., Nienhius A. W. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of Human. MDRI. Science 1992; 257: 99–103
   PubMed Web of Science ®Google Scholar
• Hanania E. G., Deisseroth A. B. Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Therapy 1994; 1: 21–26
   PubMed Web of Science ®Google Scholar
• Bertolini F., De Monte L., Corsini C., Lazzari L., Lauri E., Soligo D., Malavasi F., Ward M., Bank A., Sirchia G. Transfer of the the multidrug resistance gene into human hematopoietic progenitors collected from bone marrow, peripheral blood and cord blood. Blood 1994; 84, (Suppl 1)
   Web of Science ®Google Scholar
• Ward M., Richardson C., Pioli P., Avello J., Reiss R., Hesdorffer C., Bank A. MDR gene transfer and expression into peripheral blood progenitor cells. Blood 1994; 84, (Suppl 1)
   Google Scholar
• Traycoff C. M., Abboud M. R., Laver J., Clapp D. W., Srour E. F. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential. Exp. Hematol 1994; 22: 1264–1272
   PubMed Web of Science ®Google Scholar
• Schibler K. R., Li Y., Ohls R. K., Nye N. C., Durham M. C., White W., Liechty K. W., Le T., Christensen R. D. Possible mechanisms accounting for the growth factor independence of hematopoietic progenitors from umbilical cord blood. Blood 1994; 84: 3679–3684
   PubMed Web of Science ®Google Scholar
• Clinical protocol. Human MDR gene transfer in patients with advanced cancer. Human Gene Therapy, 5: 1151–1160
   PubMed Web of Science ®Google Scholar
• Clinical protocol. Retroviral mediated transfer of the human MDR1 gene into hematopoietic stem cells during autologous transplantation after invasive chemotherapy for metastatic breast cancer. Human Gene Therapy, 5: 891–911
   PubMed Web of Science ®Google Scholar
• Clinical protocol. Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hemetopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial. Human Gene Therapy, 5: 1507–1522
   PubMed Web of Science ®Google Scholar